-7%

est. 2Y upside i

Healthcare

Rank

#3757

Sector

Health Tech / Employee Benefits

Est. Liquidity

~4Y

Data Quality

Data: Low

Radical Health operates in a crowded, incumbent-dominated space where UnitedHealth/Optum, Aetna/CVS, and Accolade (ACCD, ~$400M revenue) all compete directly, and AI benefits navigation capabilities are rapidly commoditizing — making the company's thin moat and early-stage position particularly vulnerable.

Last updated: April 3, 2026

Bull (10%)+200%

A major HR platform (Workday, ADP) or large insurer acquires Radical Health as an AI capability bolt-on at a strategic premium, valuing its employer relationships and proprietary benefits-navigation data at 15–20x ARR. This would require the company to first demonstrate $30–50M+ ARR and measurable cost-reduction outcomes for employers — a plausible but narrow path given the competitive field.

Base (45%)+15%

Radical Health carves out a niche with mid-market employers (500–5,000 employees) where Accolade and Quantum Health are less focused, growing to $15–25M ARR by 2028 and exiting via a small acquisition or merger at a modest 8–12x revenue multiple — roughly in line with today's entry price for employees given dilution from future rounds.

Bear (45%)-75%

UnitedHealth (Optum), Aetna/CVS, or Cigna each launch or expand proprietary AI benefits navigation tools embedded directly into their carrier relationships — making Radical Health's standalone platform redundant; simultaneously Accolade (ACCD) continues consolidating the employer market, and Radical Health struggles to reach product-market fit, resulting in a down round or acqui-hire that leaves common stockholders with near-zero recovery.

Est. time to liquidity~4.0 years

Preference Stack Risk

moderate

Total funding and current valuation are undisclosed (data confidence: low), so preference stack cannot be precisely calculated — but as an early-stage venture-backed company, typical Series A/B structures would place $5–20M+ in liquidation preferences ahead of common stock, meaning employees may receive little in a flat or down-exit.

Dilution Risk

high

Founded in 2021 and likely pre-revenue scale, Radical Health will almost certainly require 2–3 additional funding rounds before reaching a liquidity event, likely diluting current employee equity by 30–50% cumulatively.

Secondary Liquidity

none

No evidence of secondary market activity or tender offers; employees should expect equity to be fully illiquid for 3–5+ years.

Questions to Ask at the Interview

Strategic questions based on Radicalhealth's data — designed to show you've done your homework.

  • 1

    “Accolade and Quantum Health are both investing heavily in AI-driven navigation for self-insured employers — how does Radical Health's product win against a Accolade Health Assistant or Optum's Advocate4Me when a CFO compares them side by side on cost reduction data?”

  • 2

    “Given that the TAM penetration across all vendors is only ~10%, what is the company's current ARR and net revenue retention rate, and how quickly does the company expect to reach break-even given its PEPM model?”

  • 3

    “What is the current funding runway and timeline to the next round — and has the board discussed any secondary liquidity options (tender offer, secondary market) for employees given the company was founded in 2021 and early employees may have significant vested equity?”

Community

Valuation Sentiment

Our model estimates -7% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.